Rizwan Masood

Rizwan Masood

Auto-generated profile, based on publicly available information

Rizwan Masood

Department of Otolaryngology–Head and Neck Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2003 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
RMRizwan Masood
Rizwan Masood
AKAjay Kundra
Ajay Kundra
SZSuTao Zhu
SuTao Zhu
GXGuangbin Xia
Guangbin Xia
Pierluigi ScaliaPierluigi Scalia
Pierluigi Scalia
PGParkash S. Gill
Parkash S. Gill
Malignant mesothelioma (MM) is a locally aggressive tumor that originates from the mesothelial cells of the pleural and sometimes peritoneal surface. Conventional treatments for MM, consisting of chemotherapy or surgery give little survival benefit to patients, who generally die within 1 year of diagnosis. Hence, there is an urgent need for the development of alternative therapies. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for MM. The closely related molecule, VEGF‐C, is also implicated in malignant mesothelioma growth. VEGF‐C and its cognate receptor VEGFR‐3 are co‐expressed in mesothelioma cell lines. A functional VEGF‐C autocrine growth loop was demonstrated in mesothelioma cells by targeting VEGF‐C expression and binding to VEGFR‐3. The ability of novel agents that reduce the levels of VEGF and VEGF‐C to inhibit mesothelioma cell growth in vitro was assessed. Antisense oligonucleotide (ODN) complementary to VEGF that inhibited VEGF and VEGF‐C expression simultaneously specifically inhibited mesothelioma cell growth. Similarly, antibodies to VEGF receptor (VEGFR‐2) and VEGF‐C receptor (VEGFR‐3) were synergistic in inhibiting mesothelioma cell growth. In addition, a diphtheria toxin‐VEGF fusion protein (DT‐VEGF), which is toxic to cells that express VEGF receptors was very effective in inhibiting mesothelioma cell growth in vitro. These results indicate that targeting VEGF and VEGF‐C simultaneously may be an effective therapeutic approach for malignant mesothelioma.

9 September 2013 in Oncogenesis
Verified
Journal Article
Open access
PDF file
RMR Masood
R Masood
CHC Hochstim
C Hochstim
BCB Cervenka
B Cervenka
SZS Zu
S Zu
SBS K Baniwal
S K Baniwal
USU K Sinha
U K Sinha
Prognosis of head and neck squamous cell carcinoma (HNSCC) is largely determined by the extent of lymph node (LN) metastasis at diagnosis, and this appears to be controlled by cancer cell genetics. To examine the role of these genes in LN metastasis, we created a human-in-mouse orthotopic model of HNSCC and performed comparative microarray analysis of gene expression between populations of HNSCC cell lines derived before and after serial transplantation and in vivo metastasis in mice. Microarray analysis comparing the USC-HN3-GFP, USC-HN3-GFP-G1 and USC-HN3-GFP-G2 cell lines identified overexpression of genes implicated in epithelial-to- mesenchymal transition and the formation of cancer stem cells, including CAV-1, TLR-4 (Toll-like receptor 4), MMP-7 (matrix metalloproteinase 7), ALDH1A3, OCT-4 and TRIM-29. Ingenuity Pathway Analysis confirmed upregulation of respective gene signaling pathways in the USC-HN1-GFP-G2 cell line. Patient HNSCC samples from advanced stages overexpressed ALDH1A3, CAV-1 and MMP-7. Our results show that CAV-1, TLR-4, MMP-7, ALDH1A3, OCT-4 and TRIM-29 have increased expression in HNSCC cells selected for an enhanced metastatic phenotype and suggest that these genes may have an important role in the metastatic potential of HNSCC cells. Inhibition of these genes may therefore have prognostic and therapeutic utility in HNSCC.

22 February 2010 in Head & Neck Oncology
Verified
Journal Article
Open access
PDF file
DLDaniel J Liebertz
Daniel J Liebertz
MLMelissa G Lechner
Melissa G Lechner
RMRizwan Masood
Rizwan Masood
USUttam Sinha
Uttam Sinha
JHJing Han
Jing Han
AEAlan Epstein
Alan Epstein
Background: Head and neck squamous cell carcinoma (HNSCC) is an aggressive and lethal malignancy. Publically available cell lines are mostly of lingual origin, or have not been carefully characterized. Detailed characterization of novel HNSCC cell lines is needed in order to provide researchers a concrete keystone on which to build their investigations. Methods: The USC-HN1 cell line was established from a primary maxillary HNSCC biopsy explant in tissue culture. The immortalized cells were then further characterized by heterotransplantation in Nude mice; immunohistochemical staining for relevant HNSCC biomarkers; flow cytometry for surface markers; cytogenetic karyotypic analysis; human papillomavirus and Epstein-Barr virus screening; qRT-PCR for oncogene and cytokine analysis; investigation of activated, cleaved Notch1 levels; and detailed 35,000 gene microarray analysis. Results: Characterization experiments confirmed the human HNSCC origin of USC-HN1, including a phenotype similar to the original tumor. Viral screening revealed no HPV or EBV infection, while western blotting displayed significant upregulation of activated, cleaved Notch1. Conclusions: USC-HN1, a novel immortalized cell line has been derived from a maxillary HNSCC. Characterization studies have shown that the cell line is of HNSCC origin and displays many of the same markers previously reported in the literature. USC-HN1 is available for public research and will further the investigation of HNSCC and the development of new therapeutic modalities.

14 January 2011 in Head & Neck
Verified
Journal Article
Closed access
PDF file
USUttam K. Sinha
Uttam K. Sinha
VSVictor J. Schorn
Victor J. Schorn
CHChristian Hochstim
Christian Hochstim
SCSteven B. Chinn
Steven B. Chinn
SZSutao Zhu
Sutao Zhu
RMRizwan Masood
Rizwan Masood

1 January 2012 in Integrative Biology
Verified
Journal Article
Closed access
PDF file
RMRizwan Masood
Rizwan Masood
IRIndrajit Roy
Indrajit Roy
SZSutao Zu
Sutao Zu
CHChristian Hochstim
Christian Hochstim
KYKen-Tye Yong
Ken-Tye Yong
PPParas N. Prasad
Paras N. Prasad
A unique theragonostic approach of gene delivery is based on a synergistic combination of gold nanorods (GNRs) and small interfering RNA (siRNA) nanoplexes.

15 September 2008 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
EYEric J. Yavrouian
Eric J. Yavrouian
USUttam K. Sinha
Uttam K. Sinha
DRDale H. Rice
Dale H. Rice
MSMuhammad T. Salam
Muhammad T. Salam
PGParkash S. Gill
Parkash S. Gill
RMRizwan Masood
Rizwan Masood
Head and neck squamous cell carcinoma (HNSCC) is an epithelial cancer that arises in the mucosa of the upper aerodigestive tract.1 It commonly affects the oral cavity, oropharynx, hypopharynx, and larynx.2 Head and neck squamous cell carcinoma is the sixth most common cancer worldwide, comprising about 4% of all malignant neoplasms, with 900 000 cases worldwide each year.3 In the United States, it was estimated that in 2008 there would be 48 000 cases and 11 000 deaths from the disease. Men are significantly more affected than women, with increased incidence and mortality among African American men.4 Important risk factors associated with the development of HNSCC are tobacco and alcohol use; therefore, abstinence from smoking and drinking is the best mode of prevention.5